Cleared Special

K042568 - EXCELSIOR 1018 AND SL-10 MICROCATHETERS

K042568 is an FDA 510(k) clearance for EXCELSIOR 1018 AND SL-10 MICROCATHETERS, manufactured by Boston Scientific Corp. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Special 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2004
Decision
24d
Days
Class 2
Risk

K042568 is an FDA 510(k) clearance for the EXCELSIOR 1018 AND SL-10 MICROCATHETERS. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Boston Scientific Corp (Fremont, US). The FDA issued a Cleared decision on October 15, 2004 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific Corp devices

FDA 510(k) Submission Details - K042568

510(k) Number K042568 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2004
Decision Date October 15, 2004
Days to Decision 24 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 125d · This submission: 24d
Pathway characteristics
Modification to existing cleared device.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 780
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K042568.
SAILOR PLUS PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER, MODEL SAEXXXXXXXXX
K042538 · Invatec Innovative Technologies · Nov 2004
POLARCATH PERIPHERAL BALLOON CATHETER SYSTEM
K042230 · Cryo Vascular Systems, Inc. · Nov 2004
RADIANT MEDICAL ENDOCATHETER TEMPERATURE PROBE
K042388 · Radiant Medical · Oct 2004
MODIFICATION TO POLARCATH PERIPHERAL DILATATION SYSTEM
K042541 · Cryo Vascular Systems, Inc. · Oct 2004
ATTAIN SELECT 6238TEL GUIDE CATHETER SET FOR LEFT-HEART DELIVERY
K042194 · Medtronic Vascular · Sep 2004
MODIFIED CONCENTRIC RETRIEVER, MODEL 90038
K040745 · Concentric Medical, Inc. · Aug 2004